Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Cardinal Health (CAH) NYSE

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 24,014,330
  • Shares Outstanding, K 319,950
  • Annual Sales, $ 121,546 M
  • Annual Income, $ 1,427 M
  • 36-Month Beta 0.72
  • Price/Sales 0.20
  • Price/Book 3.68

Price Performance

See More
Period Period Low Period High Performance
1-Month
71.72 +4.20%
on 12/30/16
75.97 -1.63%
on 01/10/17
+1.85 (+2.54%)
since 12/23/16
3-Month
62.70 +19.19%
on 11/08/16
75.97 -1.63%
on 01/10/17
-0.88 (-1.16%)
since 10/24/16
52-Week
62.70 +19.19%
on 11/08/16
87.85 -14.93%
on 04/21/16
-6.86 (-8.41%)
since 01/22/16

Most Recent Stories

More News
McKesson (MCK) Q3 Earnings: Stock Likely to Disappoint?

McKesson Corporation (MCK), one of the largest healthcare services providers, is scheduled to report third-quarter fiscal 2017 results on Jan 25.

ABC : 84.43 (-0.53%)
MCK : 148.41 (-0.61%)
CAH : 74.75 (+0.04%)
ABBV : 60.34 (-1.02%)
Vial Adaptors for Reconstitution Drug Market to be Worth US$1.3 Billion by 2024: Reduced Risk of Needlestick Injuries Ups Demand, Notes TMR

ALBANY, New York, January 19, 2017 /PRNewswire/ --

BAX : 45.90 (-0.26%)
WST : 84.39 (+2.42%)
CAH : 74.75 (+0.04%)
Vial Adaptors for Reconstitution Drug Market to be Worth US$1.3 Billion by 2024: Reduced Risk of Needlestick Injuries Ups Demand, Notes TMR

The Global Vial Adaptor for Reconstitution Drug Market is fairly consolidated as top four players hold a leading share in the global market. A report by Transparency Market Research states that West Pharmaceutical...

BAX : 45.90 (-0.26%)
WST : 84.39 (+2.42%)
CAH : 74.75 (+0.04%)
McKesson (MCK) to Pay $150 Million to Department of Justice

McKesson (MCK) has finalized to resolve U.S. Drug Enforcement Administration and Department of Justice potential federal civil and administrative claims.

ABC : 84.43 (-0.53%)
MCK : 148.41 (-0.61%)
CAH : 74.75 (+0.04%)
ACET : 19.72 (+0.25%)
Feds: McKesson agrees to pay $150M in pill shipment case

CHARLESTON, W.Va. (AP) — A major California-based drug wholesaler has agreed to pay $150 million to settle allegations that it failed to detect and report pharmacies' suspicious orders of prescription...

MCK : 148.41 (-0.61%)
CAH : 74.75 (+0.04%)
Cardinal Health Becomes #172 Most Shorted S&P 500 Component, Replacing DTE Energy

The most recent short interest data has been released for the 12/30/2016 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the...

CAH : 74.75 (+0.04%)
West Virginia gets $36M to end suit against 2 drug companies

CHARLESTON, W.Va. (AP) — Two major prescription drug distributors have agreed to pay $36 million to settle a West Virginia lawsuit alleging they fueled West Virginia's opioid epidemic with excessively...

CAH : 74.75 (+0.04%)
Cardinal Health to Webcast Discussion of Second-Quarter Results for Fiscal Year 2017 on Feb. 7

Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2017 on Feb. 7, prior to the opening of trading on the New York Stock Exchange. The company will webcast...

CAH : 74.75 (+0.04%)
Should Value Investors Pick Cardinal Health (CAH)?

Cardinal Health is an inspired choice for value investors, as it is hard to beat its incredible lineup of statistics on this front.

CAH : 74.75 (+0.04%)
West Virginia settling drug suit against 2 more distributors

CHARLESTON, W.Va. (AP) — Two major prescription drug distributors have agreed to settle a West Virginia lawsuit alleging they fueled West Virginia's opioid epidemic with excessively large shipments of...

CAH : 74.75 (+0.04%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More

Business Summary

Cardinal Health, Inc. is one of the leading providers of products and services to healthcare providers and manufacturers to help them improve the efficiency and quality of healthcare. These services and products include Pharmaceutical Distribution and Provider Services, Medical-Surgical Products and...

See More

Support & Resistance

2nd Resistance Point 75.55
1st Resistance Point 75.14
Last Price 74.75
1st Support Level 74.29
2nd Support Level 73.85

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.